Pierre-André Gilormini

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 6

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Chemical science

International journal of molecular sciences

Organic & biomolecular chemistry

Simon Fraser University

Université Lille 1 (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Simon Fraser University Dec 09 2018

Canada

Post-doctoral fellow :: Chemistry

Université de Lille 1 UFR de Chimie Sep 01 2017 - Aug 31 2018

France

Research and Teaching Temporary Assistant (ATER) :: Unité de Glycobiologie Structurale et Fonctionnelle (UMR CNRS - 8576)

Education History

Université Lille 1 Oct 01 2014 - Aug 31 2017

France

PHD :: Unité de Glycobiologie Structurale et Fonctionnelle (UGSF - UMR-CNRS 8576)

Université Lille 1

France

MSC :: Chemical Biology

University of Picardie Jules Verne

France

BSC :: Chemistry and Biology

Publications

Pierre-André Gilormini, V Narasimharao Thota, Anthony Fers-Lidou, Roger A Ashmus, Matthew Nodwell, Jacob Brockerman, Chu-Wei Kuo, Yang Wang, Taylor E Gray, Nitin, Anthony W McDonagh, Shih-Yun Guu, Nurşah Ertunç Hasbal, Dominick Yeo, Wesley F Zandberg, Kai-Hooi Khoo, Robert A Britton, David J Vocadlo
A metabolic inhibitor blocks cellular fucosylation and enables production of afucosylated antibodies. Proceedings of the National Academy of Sciences of the United States of America 121 (27) (2024)
Pierre-André Gilormini, V Narasimharao Thota, Anthony Fers-Lidou, Roger A Ashmus, Matthew Nodwell, Jacob Brockerman, Chu-Wei Kuo, Yang Wang, Taylor E Gray, Nitin, Anthony W McDonagh, Shih-Yun Guu, Nurşah Ertunç Hasbal, Dominick Yeo, Wesley F Zandberg, Kai-Hooi Khoo, Robert A Britton, David J Vocadlo
A metabolic inhibitor blocks cellular fucosylation and enables production of afucosylated antibodies. Proceedings of the National Academy of Sciences of the United States of America 121 (27) (2024)
Pierre-André Gilormini, V Narasimharao Thota, Anthony Fers-Lidou, Roger A Ashmus, Matthew Nodwell, Jacob Brockerman, Chu-Wei Kuo, Yang Wang, Taylor E Gray, Nitin, Anthony W McDonagh, Shih-Yun Guu, Nurşah Ertunç Hasbal, Dominick Yeo, Wesley F Zandberg, Kai-Hooi Khoo, Robert A Britton, David J Vocadlo
A metabolic inhibitor blocks cellular fucosylation and enables production of afucosylated antibodies. Proceedings of the National Academy of Sciences of the United States of America 121 (27) (2024)
Roger A Ashmus, Yang Wang, Manuel González-Cuesta, Dustin T King, Ben Tiet, Pierre-André Gilormini, José Manuel García Fernández, Carmen Ortiz Mellet, Robert A Britton, David J Vocadlo
Rational design of cell active C2-modified DGJ analogues for the inhibition of human α-galactosidase A (GALA). Organic & biomolecular chemistry 19 (37) (2021)
Lan-Yi Chang, Elin Teppa, Maxence Noel, Pierre-André Gilormini, Mathieu Decloquement, Cédric Lion, Christophe Biot, Anne-Marie Mir, Virginie Cogez, Philippe Delannoy, Kay Hooi Khoo, Daniel Petit, Yann Guerardel, Anne Harduin-Lepers
Novel Zebrafish Mono-α2,8-sialyltransferase (ST8Sia VIII): An Evolutionary Perspective of α2,8-Sialylation. International journal of molecular sciences 20 (3) (2019)
Pierre-André Gilormini, Anna R Batt, Matthew R Pratt, Christophe Biot
Asking more from metabolic oligosaccharide engineering. Chemical science 9 (39) (2018)

Pierre-André Gilormini.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Pierre-André Gilormini